ReviewThe Journal of international medical research2026
The evidence for the use of peripheral blood indices in the diagnosis of breast cancer.
Review in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diagnosis at early stages is critical for achieving favorable outcomes in patients with breast cancer. However, early breast cancer is characterized by atypical clinical and imaging manifestations, which are misdiagnosed as benign breast disease. This misdiagnosis may affect the choice of treatment, delay the patient's condition, and affect survival. Therefore, identifying an effective and simple screening method to supplement existing screening methods is of considerable importance for improving diagnostic efficacy. Peripheral blood indices are simple, economical, and readily accessible that include routine blood indices, lipid indices, and coagulation indices. With in-depth research on tumor pathogenesis, the relationships between these indices and tumor development have been gradually revealed, suggesting their potential as diagnostic factors for breast cancer. This narrative review explores the development of peripheral blood indices for diagnosing breast cancer and their potential use in early diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.